Acoustic Neuromas: General Considerations
I. Doğan, Burak Ozaydin, J. Roche, M. Başkaya
Published 2019 · Medicine
Download PDFAnalyze on Scholarcy
VS account for approximately 6–8% of intracranial tumors in adults and are the most common tumor in the CPA ranging between 80% and 95%. Vestibular schwannomas constitute 6% of all intracranial neoplasms and are the most common benign lesions of the IAC and CPA cistern constituting between 60% and 90% of the entire lesions seen in this area. Growth rates in tumors that exhibit enlargement have been reported to be about 1–2 mm per year in linear growth in at least one dimension. While no formal consensus exists, most authors define normal growth rates as being between 1 and 2 mm per year and fast growth rates as 4 mm or greater per year. When considering common presenting manifestations, a helpful framework is to consider manifestations based on the size of the tumor, and its location; intracanalicular, cisternal, brainstem compressive, or hydrocephalic sizes. While any configuration is possible, hearing loss associated with vestibular schwannomas of this size is typically unilateral, progressive, and commonly affects high-frequency thresholds and speech perception. An occipital headache attributable to the tumor is a late finding with 20% of patients with tumors between 1 and 3 cm, with 40% of patients with tumors larger than 3 cm verifying this symptom. Gross total resection is the goal of surgery while maintaining good facial function, in all sizes of tumors, and hearing preservation, in small to moderate size tumors in patients with serviceable preoperative hearing status.
This paper references
The natural history of untreated acoustic neuromas.
B. Strasnick (1994)
Analysis of patterns of care of brain tumor patients in the United States: a study of the Brain Tumor Section of the AANS and the CNS and the Commission on Cancer of the ACS.
M. S. Mahaley (1990)
Diagnosis of small vestibular schwannomas using constructive interference steady state sequence.
Adam A. Liudahl (2018)
Asymptomatic acoustic neurilemoma.
J. R. Leonard (1970)
Rare Tumors of the Cerebellopontine Angle
D. Brackmann (1980)
The Management and Imaging of Vestibular Schwannomas
E. P. Lin (2017)
Evolution of vestibular schwannoma surgery: the long journey to current success.
A. Koerbel (2005)
[Incidence of vestibular schwannoma in Denmark].
Sven-Eric Stangerup (2008)
Conservative management of acoustic neuromas.
J. Nedzelski (1992)
Update on Conservative Management of Acoustic Neuroma
D. Hoistad (2001)
Single Institutional Experience With Observing 564 Vestibular Schwannomas: Factors Associated With Tumor Growth
J. Hunter (2016)
Prevalence of Unsuspected Acoustic Neuroma Found by Magnetic Resonance Imaging
T. Anderson (2000)
The incidence of acoustic neuromas.
J. Nestor (1988)
Hearing preservation in vestibular schwannoma management.
Anna H. Elliott (2015)
Incidence and growth pattern of vestibular schwannomas in a Danish county, 1977-98.
F. Mirz (2000)
Nerve origin of vestibular schwannoma: a prospective study.
T. Khrais (2008)
Decision Making in the Wait-and-Scan Approach for Vestibular Schwannomas: Is There a Price to Pay in Terms of Hearing, Facial Nerve, and Overall Outcomes?
Sampath Chandra Prasad (2018)
Results of present day operations for acoustic tumors.
Gilbert Horrax (1949)
Clinical behavior of acoustic tumors. A flow cytometric analysis.
L. Kesterson (1993)
Conservative management of 386 cases of unilateral vestibular schwannoma: tumor growth and consequences for treatment.
W. E. Bakkouri (2009)
Long-Term Hearing Preservation in Vestibular Schwannoma
Sven-Eric Stangerup (2010)
Incidence of vestibular schwannoma in Denmark, 1977-1995.
M. Howitz (2000)
Management of benign cranial nonacoustic schwannomas by fractionated stereotactic radiotherapy
A. Zabel (2001)
Vestibular schwannoma (acoustic neuroma).
Derald E. Brackmann (2012)
Hearing outcomes of vestibular schwannoma patients managed with 'wait and scan': predictive value of hearing level at diagnosis.
Sven-Eric Stangerup (2010)
Complications of Microsurgery of Vestibular Schwannoma
Jan Betka (2014)
Tumors of the Nervus Acusticus, and the Syndrome of the Cerebellopontile Angle
H. Cushing (2010)
Change in hearing during 'wait and scan' management of patients with vestibular schwannoma.
S-E Stangerup (2008)
Part IV. Surgical Technique and Complications: Evolution of Transtemporal Bone Removal of Acoustic Tumors
W. House (1964)
Acoustic neuroma: clinical aspects, audiovestibular assessment, diagnostic delay, and growth rate.
J. Thomsen (1990)
Clinical growth rate of acoustic schwannomas: correlation with the growth fraction as defined by the monoclonal antibody ki-67.
T. Lesser (1991)
What is the real incidence of vestibular schwannoma?
M. Tos (2004)
Management of 1000 vestibular schwannomas (acoustic neuromas): clinical presentation.
C. Matthies (1997)
True Incidence of Vestibular Schwannoma?
Sven-Eric Stangerup (2010)
Comparison of Growth Patterns of Acoustic Neuromas With and Without Radiosurgery
A. Battaglia (2006)
Audiometric findings in patients with acoustic neuroma.
S. Harner (2000)
The prevalence of "incidental" acoustic neuroma.
D. Lin (2005)
Surgical approaches to acoustic tumors.
W. Hitselberger (1966)
Rare tumours of the cerebellopontine angle.
D. Moffat (1995)
Diagnostic Accuracy of Screening MR Imaging Using Unenhanced Axial CISS and Coronal T2WI for Detection of Small Internal Auditory Canal Lesions
T. Abele (2014)
History of vestibular schwannoma surgery.
W. Pellet (2008)
Conservative treatment of patients with acoustic tumors.
J. Bederson (1991)
Audiometric findings in patients with acoustic neuroma. Commentary
S. Harner (2000)
Effectiveness of conservative management of acoustic neuromas.
Y. J. Shin (2000)
Atypical hearing loss in acoustic neuroma patients.
S. Selesnick (1993)
The Natural History of Vestibular Schwannoma
Sven-Eric Stangerup (2006)
Radiologic surveillance of acoustic neuromas.
S. Selesnick (1998)
The proliferative activity of neurilemomas.
K. Lee (1989)
Merlin, the neurofibromatosis type 2 gene product, and beta1 integrin associate in isolated and differentiating Schwann cells.
V. J. Obremski (1998)
The Top 50 Most-Cited Articles on Acoustic Neuroma.
Abrar Alfaifi (2018)
Tumors of the cerebellopontine angle. Changing policy in treatment
Miklós Horváth (2004)
The bloody angle: 100 years of acoustic neuroma surgery.
Ramsden Rt (1995)
Descriptive epidemiology of vestibular schwannomas.
J. Propp (2006)
Conservative management of unilateral acoustic neuromas.
D. Tschudi (2000)
Epidemiology and natural history of vestibular schwannomas.
Sven-Eric Stangerup (2012)
REMOVAL OF CEREBELLOPONTILE (ACOUSTIC) TUMORS THROUGH A UNILATERAL APPROACH
W. E. Dandy
Nonvestibular schwannoma tumors in the cerebellopontine angle: a structured approach and management guidelines.
J. Springborg (2008)
A review of the symptoms and signs of acoustic neurofibromata.
C. H. Edwards (1951)
Paediatric presentation of type 2 neurofibromatosis
D. Evans (1999)
Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2
G. Rouleau (1993)
Cerebellopontine angle epidermoid cysts: clinical presentations and surgical outcome
M. Hasegawa (2015)
EARLY ASYMPTOMATIC ACOUSTIC TUMOR: REPORT OF SIX CASES
Mary Hardy (1936)